54 results on '"Saftoiu, Adrian"'
Search Results
2. A brief report on EFSUMB Guidelines and Recommendations for elastography and contrast-enhanced ultrasound.
- Author
-
Constantinescu, Codruța, Saftoiu, Adrian, and Constantinescu, Codruta
- Subjects
- *
CONTRAST-enhanced ultrasound , *ELASTOGRAPHY , *MEDICAL societies , *GUIDELINES , *BIOPSY , *TISSUE wounds - Abstract
. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
3. Perioperative inflammatory response in natural orifice translumenal endoscopic surgery.
- Author
-
Georgescu, Ion, Saftoiu, Adrian, Patrascu, Stefan, Silosi, Isabela, Georgescu, Eugen, and Surlin, Valeriu
- Subjects
- *
PERIOPERATIVE care , *INFLAMMATION , *NATURAL orifice transluminal endoscopic surgery , *COMPARATIVE studies , *LAPAROSCOPIC surgery , *OVARIECTOMY , *CYTOKINES - Abstract
Background: Natural orifice translumenal endoscopic surgery (NOTES) could offer multiple advantages compared with the laparoscopic approach. One such potential advantage, not yet proven, is the inferior inflammatory response, which translates into less significant operative stress. This study aimed to compare the immuno-inflammatory response between transgastric NOTES and laparoscopy for simple surgical procedures (oophorectomy) with reference to the cytokine levels. Methods: For this study, 20 female pigs were randomly assigned to either NOTES or laparoscopic oophorectomy. Seven animals were used as a control group and received only general anesthesia, with no other procedure performed. Blood samples were obtained before surgery, 1 h after the start of the procedure, and at the end of the intervention. The serum levels of IL1β and IL6 were determined using a porcine enzyme-linked immunosorbent assay (ELISA) kit. The mean operative time, intraoperative incidents, and postoperative complications were recorded. On postoperative day 14, the animals were killed, and gastric leak tests were performed. Results: Both the NOTES and laparoscopic procedures were successfully completed. No gastric leaks were observed during necropsy. The transgastric oophorectomy required a significantly longer time to perform than the laparoscopic surgery. Compared with the NOTES procedures, laparoscopic oophorectomy resulted in significantly higher levels of interleukin-1β (IL1β) (42.34 ± 5.26 ng/ml with NOTES vs 46.93 ± 4.79 ng/ml with laparoscopy; p = 0.028) and IL6 (66.95 ± 7.29 ng/ml with NOTES vs 71.75 ± 4.76 ng/ml with laparoscopy, p = 0.049) during the postoperative phase. No statistical difference was detected between the pre- and postoperative cytokine levels in the NOTES group. Conclusion: The study findings suggest that pure transgastric endoscopic surgery is a safe approach resulting in less perioperative inflammatory response than laparoscopy in the early postoperative phase. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
4. Confocal Laser Endomicroscopy of the Colon.
- Author
-
Gheonea, Dan Ionut, Saftoiu, Adrian, Ciurea, Tudorel, Popescu, Carmen, Georgescu, Claudia Valentina, and Malos, Anca
- Subjects
- *
COLON examination , *ENDOSCOPY , *PATHOLOGY , *INTESTINAL diseases , *PREVENTIVE medicine , *COLONOSCOPY , *HISTOPATHOLOGY , *MUCOUS membranes , *CILIA & ciliary motion - Abstract
Confocal laser endomicroscopy (CLE) has been recently proposed as a new technique that allows in vivo histologic assessment of mucosa during endoscopy. The most commonly used contrast agents are acriflavine hydrochloride and fluorescein sodium. For colon pathology assessment, the administration of fluorescein intravenously produces a strong staining of both surface epithelium and deeper layers of lamina propria. Confocal laser endomicroscopy is a feasible method to diagnose colon cancer in vivo. Furthermore, confirmation of neoplastic changes using CLE during colonoscopy may lead to major improvements in the clinical management of the patients with inflammatory bowel disease. Biopsies can be limited to targeted sampling of relevant lesions. Confocal laser endomicroscopy will certainly play an important diagnostic role during gastrointestinal endoscopy in the future, enabling the elimination of the diagnostic delay associated with conventional biopsy preparation and processing. [ABSTRACT FROM AUTHOR]
- Published
- 2010
5. Vascular Endothelial Growth Factor Expression and Microvessel Density -- Two Useful Tools for the Assessment of Prognosis and Survival in Gastric Cancer Patients.
- Author
-
Iordache, Sevastita, Saftoiu, Adrian, Georgescu, Claudia-Valentina, Ramboiu, Sandu, Gheonea, Dan-Ionut, Filip, Monalisa, Schenker, Michael, and Ciurea, Tudorel
- Subjects
- *
VASCULAR endothelial growth factors , *CANCER patients , *CYTOKINES , *METASTASIS , *PATHOLOGY , *HEMORRHAGE , *ENDOSCOPIC ultrasonography , *MEDICAL imaging systems , *DIAGNOSTIC imaging , *NEOVASCULARIZATION - Abstract
Background and aims. The role of angiogenesis in progression and metastasis of gastric cancer has been studied over the last years. The aim of our study was to assess the microvessel density and vascular endothelial growth factor (VEGF) expression in correlation with prognosis, survival and the risk for upper gastrointestinal (GI) bleeding as well. Method. We prospectively assessed angiogenesis in 40 patients with gastric carcinoma. Microvessel density was calculated using CD31 and CD34 markers, and VEGF expression was assessed in biopsy samples. The tumor stage was established using imaging methods: CT scan for M and N stage and endoscopic ultrasound for T and N stages. The correlation between pathological markers and tumor stage, survival rate and risk of upper gastrointestinal bleeding was assessed. Results. The study included 40 patients with gastric cancer; among them 8 patients presented with upper GI bleeding. The average microvessel density was 10.21 for CD31 and 11.85 for CD34 in all patients VEGF was positive only in 45% of patients. The microvessel density was higher in patients with advanced TNM stage, and a correlation with the risk of UGIB and survival rate was also found. VEGF expression correlated with TNM stage and with the risk of upper GI bleeding. Conclusions. Microvessel density (estimated by CD34) was involved in locally advanced disease, while VEGF was correlated with loco-regional extension and distant metastasis in gastric cancer patients. There was a clear correlation between angiogenic parameters, survival rate and the risk of upper GI bleeding. [ABSTRACT FROM AUTHOR]
- Published
- 2010
6. Tridimensional (3D) Endoscopic Ultrasound -- a Pictorial Review.
- Author
-
Saftoiu, Adrian and Gheonea, Dan Ionut
- Subjects
- *
ENDOSCOPIC ultrasonography , *TRANSDUCERS , *DIAGNOSTIC imaging , *BLOOD vessels , *MEDICAL imaging systems , *MEDICAL research - Abstract
Tridimensional endoscopic ultrasound (3D-EUS) offers a better understanding of the spatial relations of examined lesions and allowing future assessment of the captured volume. 3D-EUS has been used with both radial and linear transducers, especially in an attempt to improve staging of esophageal, gastric, pancreatic or rectal tumors. The aim of this clinical imaging article was to show the capabilities and perspectives of linear 3D ultrasound, including contrastenhanced 3D-EUS. The 3D reconstruction images were acquired with a freehand technique through rotation (torque) of the EUS scope along its long axis. 3D acquisition of contrast-enhanced EUS images was also used. Esophageal, gastric and mediastinal tumors are easily visualized by 3DEUS reconstructions and also, 3D-EUS facilitates anatomical interpretation of the images in the pancreatobiliary area. In conclusion, the advantages of 3D reconstructions in EUS are clear and multiple, especially in the assessment of the location of tumors and their relationships with neighboring organs and blood vessels. [ABSTRACT FROM AUTHOR]
- Published
- 2009
7. Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study.
- Author
-
Mateescu, Radu Bogdan, Gheorghe, Cristian, Trifan, Anca Victorita, Saftoiu, Adrian, Seicean, Andrada, Diculescu, Mihai Mircea, Banciu, Christian, Gheorghe, Liliana Simona, Busuioc, Bogdan, Goldis, Adrian, Dobru, Daniela, Fratila, Ovidiu, Eugen, Dumitru, Bataga, Simona, Constantinescu, Gabriel, Gheonea, Dan, Tantau, Alina, Jinga, Mariana, Brisc, Ciprian, and Prelipcean, Cristina Cijevschi
- Subjects
- *
INFLAMMATORY bowel diseases , *CROHN'S disease , *ULCERATIVE colitis , *ELECTRONIC paper , *DISEASE remission - Abstract
Background & Aims: Real-world assessments of efficacy and safety of advanced therapies used for inflammatory bowel disease (IBD) patients are limited. We aimed to report safety, efficacy and treatment persistence of new molecules (infliximab, adalimumab, vedolizumab, tofacitinib, ustekinumab) in a retrospective multicentric national Romanian analysis. Methods: We conducted a nationwide, retrospective observational multicentric study. Data were collected retrospectively from electronic and paper files. Patients who started on one of the five investigated molecules during December 2019-December 2021 were included. The main outcome measures were clinical remission, endoscopic healing, persistence on treatment and safety data. Results: A total of 678 adult patients from 24 Romanian IBD centers with a diagnosis of ulcerative colitis or Crohn's disease were included. Participants had previously failure to one (268, 39.5%), two (108, 15%) or more treatment lines and only 38% (259) were biologic naïve. In the 24 months study period, most patients were started on vedolizumab (192, 28%), followed by adalimumab, infliximab, ustekinumab and tofacitinib. In biologic-naïve patients, most physicians (72%) preferred anti-TNF treatment as first line biologic (93 patients started on infliximab, 92 on adalimumab), followed by vedolizumab, ustekinumab and tofacitinib. During follow-up, 71% (470, p=0.05) of patients achieved clinical remission and 36% (134, p=0.03) achieved mucosal healing. The 6 months milestone for persistence was reached in 78% (530) of cases. Almost half of patients (47%, 316 patients) persisted on their current treatment for over 12 months. Overall, an adverse reaction was reported for 67 (10.4%) patients, with no lethal events. Conclusions: Population of biologic-experienced IBD patients in Romania is increasing and is becoming more difficult to achieve long-term disease control. Discontinuation rates for advanced therapies are high. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Performance and Safety of EUS Ablation Techniques for Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis.
- Author
-
Papaefthymiou, Apostolis, Johnson, Gavin J., Maida, Marcello, Gkolfakis, Paraskevas, Ramai, Daryl, Facciorusso, Antonio, Arvanitakis, Marianna, Ney, Alexander, Fusai, Giuseppe K., Saftoiu, Adrian, Tabacelia, Daniela, Phillpotts, Simon, Chapman, Michael H., Webster, George J., and Pereira, Stephen P.
- Subjects
- *
MEDICAL databases , *PANCREATIC cysts , *META-analysis , *CONFIDENCE intervals , *ENDOSCOPIC ultrasonography , *SYSTEMATIC reviews , *TREATMENT effectiveness , *DESCRIPTIVE statistics , *RESEARCH funding , *MEDLINE , *STATISTICAL models , *ADVERSE health care events , *ETHANOL , *PACLITAXEL , *ABLATION techniques , *PATIENT safety , *DISEASE risk factors , *EVALUATION - Abstract
Simple Summary: Pancreatic cystic lesions are diagnosed with an increasing frequency, thus comprising a significant routine condition in clinical practice. In addition to the current approaches, which include surgery and surveillance, endoscopic ultrasound (EUS) provides the potential of an additional therapeutic tool. This review collected the existing literature regarding EUS-guided ablation techniques for pancreatic cystic lesions and assessed its efficacy and safety. The cumulative effect in treating pancreatic cysts was 44% (95%CI: 31–57), with the highest rate achieved when a combination of ethanol and paclitaxel was injected into the cysts (70%; 95%CI: 64–76). Considering safety, most adverse events were mild and occurred after ethanol injection. EUS-guided pancreatic cyst ablation seems to be an acceptable and safe procedure, with promising results in appropriately selected patients. Background: Pancreatic cystic lesions (PCL) represent an increasingly diagnosed condition with significant burden to patients' lives and medical resources. Endoscopic ultrasound (EUS) ablation techniques have been utilized to treat focal pancreatic lesions. This systematic review with meta-analysis aims to assess the efficacy of EUS ablation on PCL in terms of complete or partial response and safety. Methods: A systematic search in Medline, Cochrane and Scopus databases was performed in April 2023 for studies assessing the performance of the various EUS ablation techniques. The primary outcome was complete cyst resolution, defined as cyst disappearance in follow-up imaging. Secondary outcomes included partial resolution (reduction in PCL size), and adverse events rate. A subgroup analysis was planned to evaluate the impact of the available ablation techniques (ethanol, ethanol/paclitaxel, radiofrequency ablation (RFA), and lauromacrogol) on the results. Meta-analyses using a random effects model were conducted and the results were reported as percentages with 95% confidence intervals (95%CI). Results: Fifteen studies (840 patients) were eligible for analysis. Complete cyst resolution after EUS ablation was achieved in 44% of cases (95%CI: 31–57; 352/767; I2 = 93.7%), and the respective partial response rate was 30% (95%CI: 20–39; 206/767; I2 = 86.1%). Adverse events were recorded in 14% (95%CI: 8–20; 164/840; I2 = 87.2%) of cases, rated as mild in 10% (95%CI: 5–15; 128/840; I2 = 86.7%), and severe in 4% (95%CI: 3–5; 36/840; I2 = 0%). The subgroup analysis for the primary outcome revealed rates of 70% (95%CI: 64–76; I2 = 42.3%) for ethanol/paclitaxel, 44% (95%CI: 33–54; I2= 0%) for lauromacrogol, 32% (95%CI: 27–36; I2 = 88.4%) for ethanol, and 13% (95%CI: 4–22; I2 = 95.8%) for RFA. Considering adverse events, the ethanol-based subgroup rated the highest percentage (16%; 95%CI: 13–20; I2 = 91.0%). Conclusion: EUS ablation of pancreatic cysts provides acceptable rates of complete resolution and a low incidence of severe adverse events, with chemoablative agents yielding higher performance rates. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. A Diagnostic Challenge: Pancreatic Cancer or Autoimmune Pancreatitis?
- Author
-
CAZACU, IRINA MIHAELA, CHAVEZ, ADRIANA ALEXANDRA LUZURIAGA, SAFTOIU, ADRIAN, WHITLOW, TONYA G., BHOSALE, PRIYA, and BHUTANI, MANOOP S.
- Subjects
- *
PANCREATIC cancer diagnosis , *CANCER cells , *STEROID drugs - Abstract
We report a rare case of seronegative autoimmune pancreatitis (AIP) that presented as a pancreatic focal lesion and was considered to be pancreatic cancer based on the clinical presentation and imaging findings. The endoscopic ultrasound-guided biopsies of the pancreatic mass revealed no malignant cells and the pancreatic swelling had become diffuse on repeat imaging. AIP was suspected and a trial of steroids was considered as a diagnostic and therapeutic method. The patient responded dramatically to corticosteroid treatment with resolution of symptoms and normal imagining and laboratory parameters. This case highlights the challenge in the diagnostic approach of a pancreatic mass. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Image Fusion Involving Real-Time Transabdominal or Endoscopic Ultrasound for Gastrointestinal Malignancies: Review of Current and Future Applications.
- Author
-
Singh, Ben S., Cazacu, Irina M., Deza, Carlos A., Rigaud, Bastien S., Saftoiu, Adrian, Gruionu, Gabriel, Guionu, Lucian, Brock, Kristy K., Koay, Eugene J., Herman, Joseph M., and Bhutani, Manoop S.
- Subjects
- *
IMAGE fusion , *ENDOSCOPIC ultrasonography , *GASTROINTESTINAL cancer , *COMPUTED tomography , *ULTRASONIC imaging - Abstract
Image fusion of CT, MRI, and PET with endoscopic ultrasound and transabdominal ultrasound can be promising for GI malignancies as it has the potential to allow for a more precise lesion characterization with higher accuracy in tumor detection, staging, and interventional/image guidance. We conducted a literature review to identify the current possibilities of real-time image fusion involving US with a focus on clinical applications in the management of GI malignancies. Liver applications have been the most extensively investigated, either in experimental or commercially available systems. Real-time US fusion imaging of the liver is gaining more acceptance as it enables further diagnosis and interventional therapy of focal liver lesions that are difficult to visualize using conventional B-mode ultrasound. Clinical studies on EUS guided image fusion, to date, are limited. EUS–CT image fusion allowed for easier navigation and profiling of the target tumor and/or surrounding anatomical structure. Image fusion techniques encompassing multiple imaging modalities appear to be feasible and have been observed to increase visualization accuracy during interventional and diagnostic applications. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Quantitative contrast-enhanced endoscopic ultrasound in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumors: can we predict survival using perfusion parameters? A pilot study.
- Author
-
Constantin, Alina L., Cazacu, Irina M., Burtea, Daniela Elena, Harbiyeli, Irina F. Cherciu, Bejinariu, Nona, Popescu, Carmen F., Serbanescu, Mircea S., Tabacelia, Daniela, Copaescu, Catalin, Bhutani, Manoop S., Stroescu, Cezar, and Saftoiu, Adrian
- Subjects
- *
ENDOSCOPIC ultrasonography , *ADENOCARCINOMA , *PANCREATIC cancer , *NEUROENDOCRINE tumors , *PANCREATIC intraepithelial neoplasia - Abstract
Aim: Contrast-enhanced harmonic endoscopic ultrasound (CEH-EUS) parameters may be used to predict prognosis of pancreatic ductal adenocarcinoma (PDAC) and pancreatic neuroendocrine tumors (pNET). The aim of this study was to investigate the association between several perfusion parameters on CEH-EUS performed before treatment and survival outcome in patients with PDAC or pNET. Material and methods: Thirty patients with PDAC or pNET who underwent CEH-EUS and EUS-guided fine needle aspiration (EUS-FNA) were included. Quantitative analysis of tumor vascularity was performed using time-intensity curve (TIC) analysis-derived parameters, obtained from processing CEH-EUS recordings with a commercially available software (VueBox). Cox proportional hazards models were used to determine associations with survival outcome. Results: Median overall survival (OS) for PDAC patients was 9.61 months (95% CI: 0.1-38.7) while the median OS for pNET patients was 15.81 months (95% CI: 5.8-24.75. In a multivariate model for OS, a lower peak enhancement (HR=1.76, p=0.02) and a lower wash-in area under the curve (HR=1.06, p=0.001) were associated with worse survival outcome for patients with PDAC. Conclusions: CEH-EUS parameters may be used as a surrogate to predict PDAC aggressiveness and survival before treatment. After validation by large-scale studies, CEH-EUS perfusion parameters have the potential to be used in pretreatment risk stratification of patients with PDAC and in evidence-based clinical decision support. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Romanian Guidelines on the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency.
- Author
-
Gheorghe, Cristian, Seicean, Andrada, Saftoiu, Adrian, Tantau, Marcel, Dumitru, Eugen, Jinga, Mariana, Negreanu, Lucian, Mateescu, Bogdan, Gheorghe, Liana, Ciocirlan, Mihai, Cijevschi, Cristina, Constantinescu, Gabriel, Dima, Simona, and Diculescu, Mircea
- Subjects
- *
EXOCRINE pancreatic insufficiency , *DIAGNOSIS , *DEFENSIVE medicine , *MEDICAL care , *PATIENTS - Abstract
In assessing exocrine pancreatic insufficiency (EPI), its diverse etiologies and the heterogeneous population affected should be considered. Diagnosing this condition remains a challenge in clinical practice especially for mild-to-moderate EPI, with the support of the time-consuming breath test or the coefficient of fat absorption. The fecal elastase-1 test, less precise for the diagnosis, cannot be useful for assessing treatment efficacy. Pancreatic enzyme replacement therapy (PERT) is the mainstay of treatment, whereby entericcoated mini-microspheres are taken with every meal, in progressive doses based on an individual's weight and clinical symptoms. The main indication for PERT is chronic pancreatitis, in patients who have clinically relevant steatorrhea, abnormal pancreatic function test or abnormal function tests associated with symptoms of malabsorption such as weight loss or meteorism. While enzyme replacement therapy is not recommended in the initial stages of acute pancreatitis, pancreatic exocrine function should be monitored for at least 6-18 months. In the case of unresectable pancreatic cancer, replacement enzyme therapy helps to maintain weight and improve overall quality oflife. It is also indicated in patients with celiac disease, who have chronic diarrhea (in spite of gluten-free diet), and in patients with cystic fibrosis with proven EPI. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
13. Accuracy of Endoscopic Ultrasonography for Gastric Cancer Staging.
- Author
-
SACERDOTIANU, VICTOR MIHAI, UNGUREANU, BOGDAN SILVIU, IORDACHE, SEVASTITA, FILIP, MARIA MONALISA, PIRICI, DANIEL, LILIAC, ILONA MIHAELA, and SAFTOIU, ADRIAN
- Abstract
Gastric cancer remains a health problem, with treatment indications varying with the TNM stage. We aimed in this study to highlight the role of EUS in GC patients and also to calculate the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of EUS for T and N staging in our group of patients with this disease. In this study, we included 41 GC patients, and individual values for every T stage accuracy, sensitivity, specificity, PPV, NPV, correct staging, understaging, and overstaging were calculated. EUS overall accuracy for T staging was 58.53%, with the highest sensitivity reached for the T4 stage, 95.83%. For N+vs. N-staging, EUS accuracy was 68.29%, with a sensitivity of 75% and a specificity of 44.44%. The positive and negative predicted values for the presence or absence of nodal disease were 82.75%, respectively 33.33%. In conclusion, this study confirmed the importance of EUS for the assessment of GC T and N stage and highlighted the role of this tool in the detection of liver micrometastasis unrevealed by other imaging techniques like abdominal ultrasound or MSCT. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
14. Large pancreatic mucinous cystic neoplasm during pregnancy: what should be done?.
- Author
-
Tica, Andrei Adrian, Tica, Oana Sorina, Saftoiu, Adrian, Camen, Dragos, and Tica, Vlad Iustin
- Abstract
Pancreatic mucinous cystic neoplasms are uncommon and their occurrence in pregnancy is extremely rare. The authors report the unique case of a newborn weighing 3,620 g, delivered vaginally with no complications by a patient with a large 'silent' pancreatic mucinous cystic neoplasms, and analyze the very few other reports. With no available protocol, this case highlights an interesting dilemma on the management of pregnancy and delivery as well on the timing of pancreatic surgery. Despite its limitations, MRI remains the most accurate investigation either for differentiating the mucinous from nonmucinous cysts or for evaluating the malignancy, but echography is also very useful. Without symptoms, all low-grade malignant potential tumors, independent of the moment of their diagnosis during pregnancy, should be resected 2-3 months after delivery and we believe that the best option is a term vaginal birth, even in the presence of a large cyst and large fetus. On the contrary, all high-grade malignant potential tumors, discovered in the first two trimesters of pregnancy should be resected during the second trimester, and followed by a vaginal delivery at term. If high-grade malignant potential tumor is diagnosed in the third trimester, an early vaginal delivery followed by surgery is recommended. Finally, the patient's preference is crucial. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
15. Large Pancreatic Mucinous Cystic Neoplasm during Pregnancy: What Should Be Done?
- Author
-
Tica, Andrei Adrian, Tica, Oana Sorina, Saftoiu, Adrian, Camen, Dragos, and Tica, Vlad lustin
- Subjects
- *
PREGNANCY complications , *PANCREATIC cancer , *PANCREATIC surgery , *PANCREATECTOMY , *DELIVERY (Obstetrics) - Abstract
Pancreatic mucinous cystic neoplasms are uncommon and their occurrence in pregnancy is extremely rare. The authors report the unique case of a newborn weighing 3,620 g, delivered vaginally with no complications by a patient with a large 'silent' pancreatic mucinous cystic neoplasms, and analyze the very few other reports. With no available protocol, this case highlights an interesting dilemma on the management of pregnancy and delivery as well on the timing of pancreatic surgery. Despite its limitations, MRI remains the most accurate investigation either for differentiating the mucinous from nonmucinous cysts or for evaluating the malignancy, but echography is also very useful. Without symptoms, all low-grade malignant potential tumors, independent of the moment of their diagnosis during pregnancy, should be resected 2-3 months after delivery and we believe that the best option is a term vaginal birth, even in the presence of a large cyst and large fetus. On the contrary, all high-grade malignant potential tumors, discovered in the first two trimesters of pregnancy should be resected during the second trimester, and followed by a vaginal delivery at term. If high-grade malignant potential tumor is diagnosed in the third trimester, an early vaginal delivery followed by surgery is recommended. Finally, the patient's preference is crucial. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
16. Competitive/collaborative neural computing system for medical diagnosis in pancreatic cancer detection.
- Author
-
Gorunescu, Florin, Gorunescu, Marina, Saftoiu, Adrian, Vilmann, Peter, and Belciug, Smaranda
- Subjects
- *
DIAGNOSIS , *DECISION making , *ARTIFICIAL neural networks , *PERFORMANCE evaluation , *PANCREATITIS diagnosis , *PANCREATIC cancer diagnosis , *COMPUTER network resources - Abstract
The use of computer technology to support medical decisions is now widespread and pervasive across a broad range of medical areas. Accordingly, computer-aided diagnosis has become an increasingly important area for intelligent computational systems. This paper describes a competitive/collaborative neural computing system designed to support the medical decision process using medical imaging databases. A concrete example concerning an application to support the differential diagnosis of chronic pancreatitis and pancreatic cancer is also provided. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
17. A review of telemedicine in Romania.
- Author
-
Panait, Lucian, Doarn, Charles R., Saftoiu, Adrian, Popovici, Calin, Valeanu, Vlad, and Merrell, Ronald C.
- Subjects
- *
TELEMEDICINE , *MEDICINE , *MEDICAL telematics , *MEDICAL care - Abstract
Romania is an eastern European country that is undergoing rapid reform of its medical system. We conducted an assessment of the potential for telemedicine in the country, through a literature review, personal visits to Romania and discussions with individuals from academia, the Ministry of Health and Family, and businesses. The results suggest that telemedicine has the potential to accelerate health-care reform. The main hospitals and universities could promote the wider distribution and development of telemedicine within Romania, which in turn would bring benefits to the Romanian people, 46% of whom live in rural areas. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
18. Descriptive Analysis of Patients with Gastric Tumors Referred to the Largest Emergency Hospital in Oltenia Region-Romania, Between 2015-2020.
- Author
-
LILIAC, ILONA MIHAELA, SACERDOTIANU, MIHAI VICTOR, UNGUREANU, BOGDAN SILVIU, IORDACHE, SEVASTITA, MOGOANTA, LAURENTIU, SAFTOIU, ADRIAN, and PIRICI, DANIEL
- Subjects
- *
HOSPITAL emergency services , *CAUSES of death , *AGE distribution , *AGE groups , *STOMACH cancer - Abstract
Gastric cancer represents the third most frequent cause of death worldwide, with the treatment being impaired also by the fact that patients present in the late stages of disease progression. We have aimed here to evaluate the main clinical and pathological features of all recorded cases of gastric tumor patients presented between January 2015 and December 2020 within the Emergency County Hospital of Craiova. Our retrospective analysis identified a total number of 745 cases, and showed a relative homogenous distribution of the age of the patients / year, with the peak age at presentation of 70-80 years old, and with males having a slightly higher prevalence compared to females. There was no correlation of the number of hospitalization days with the localization of the tumor, but the patients in the age group 60-70 years of age tended to show longer hospitalization times compared to the rest of the age groups. Also, pyloric/ antral tumors tended to present at younger ages compared to other localizations, and interestingly, these patients also represented most of the casuistry. Altogether, the distribution of gastric cancer patients' features did not change significantly in the last 5 years despite treatment advances (especially chemo-and radiotherapy), and the advanced stage of presentation call for a more aggressive detection and increased awareness of the population for this frequent pathology. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. EndoCuff-Assisted Colonoscopy Versus Standard Colonoscopy in Colonic Polyp Detection-Experience from a Single Tertiary Centre.
- Author
-
CALITA, MIHAELA, POPA, PETRICA, CHERCIU HARBIYELI, IRINA FLORINA, IORDACHE, SEVASTITA, CIOCALTEU, ADRIANA, FILIP, MARIA MONALISA, and SAFTOIU, ADRIAN
- Subjects
- *
VIRTUAL colonoscopy , *COLONOSCOPY , *ADENOMA , *COLON polyps , *PHYSICIANS - Abstract
Background. Standard colonoscopy fails to visualize the entire colon mucosa and consequently a significant amount of polyps are still being missed. New device, such as EndoCuff, have been developed to improve mucosal visualisation, hence the quality in colonoscopy. The aim of this study was to assess the diagnostic yield of EndoCuff-assisted colonoscopy in comparison with standard colonoscopy by taking into consideration several quality indicators. Methods. In this study, 965 adults ≥ 18 years referred for colonoscopy were randomly divided into two groups. The main statistical investigation compared the difference between EndoCuff-assisted colonoscopy (EC) vs. standard colonoscopy (SC) in the detection of colonic polyps and adenoma detection rate (ADR). The second inquiry sought to compare experienced vs. recently trained and female vs. male operators. Results. The ADR was higher for EC than for SC (37.50% vs. 26.64%). Regarding the mean number of detected polyps per procedure (MPP), the result was statistically significant when generally comparing the EC vs. SC (p=0.0009). There were no differences in MPP between EC and SC for recently trained endoscopists (p=0.7446), while a significant difference for experienced doctors (p=0,0020) was noted. A significant difference was observed between female doctors and male doctors only when using SC. EC was more helpful for female doctors when assessing MPP (p=0.0118). No serious adverse events related to EndoCuff-assisted colonoscopy was noted. Conclusions. EndoCuff-assisted colonoscopy seems to be safe and may bring benefits for improving the polyp/adenoma detection rates in regard to missed lesions, usually located in blind areas. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. PANCREATIC PSEUDOANEURYSM.
- Author
-
Musa, Adelina Mihaela, Musa, Mihai, Tieranu, Cristian George, Olteanu, Andrei, and Saftoiu, Adrian
- Subjects
- *
GASTROINTESTINAL hemorrhage , *FALSE aneurysms , *SPLENIC artery , *PANCREATIC duct , *PANCREATIC enzymes , *ALIMENTARY canal , *CHRONIC pancreatitis - Abstract
Historic. A 59-year-old patient, a chronic ethanol user, without any medical history, presents with hematemesis and abdominal pain. Methods. The level of hemoglobin was 8.2 g/dL, without any other biological modification. The emergency upper digestive endoscopy revealed a large clot that almost completely occupied the esophageal and gastric lumen, up to the duodenal angle. Endoscopic re-evaluation at 24 hours: esophagus and stomach with free lumen, gastric body with extrinsic compression on the posterior face towards the greater curvature and intensely edematous mucosa at that level. Abdominal ultrasound revealed multiple calcifications at the level of the pancreatic head and body and at the level of the tail of the pancreas, a cystic formation of approximately 5 cm was visualized, with a pulsed Doppler signal. CEUS:hyperinhancement in the center of the lesion and lack of contrast in the periphery, an aspect that was maintained in the portal and parenchymal phases. The abdominal CT showed a corporeo-caudal pancreatic pseudoaneurysm of the splenic artery with dimensions of 65 mm, with parietal thrombosis with a stratified appearance, affecting about 40% of the lumen, with contrast extravasation, in direct contact with the posterior gastric wall. Results. The suspicion of upper digestive hemorrhage secondary to a fistula between the pseudo-aneurysm of the splenic artery and the stomach was raised, but also the possibility of a wirsungorrhagia, given the direct contact of the lesion with the pancreatic tail. Abdominal angiography with angioplasty was performed, secondary to the extravasation of the contrast substance at the level of the splenic artery with a 3/18 mm Bentley type stent graft, with an optimal result, without extravasation of contrast. Diagnosis. Upper gastrointestinal hemorrhage secondary to a splenic artery pseudoaneurysm. Chronic ethanolic pancreatitis. Conclusions. Bleeding from splenic artery pseudoaneurysm is a rare and often fatal cause of gastrointestinal bleeding The most common causes are pancreatitis and abdominal trauma. In pancreatitis, pancreatic enzymes can cause vascular necrosis and rupture of elastic tissue, leading to pseudoaneurysm formation. Another way can be through pseudocysts (41% of patients with pseudoaneurysms), In this patient's case, the pseudoaneurysm most likely occurred secondary to a pseudocyst that eroded the splenic artery, with intracystic hemorrhage, which led to a localized hemorrhage and not to a hemoperitoneum, and subsequently to the digestive tract, transgastric or through the main pancreatic duct. After stent placement by angiography, the patient had a favorable evolution at ultrasound reevaluation at 1 month, with remission of the lesion. [ABSTRACT FROM AUTHOR]
- Published
- 2023
21. SCREENING OF ESOPHAGEAL VARICES NEEDING TREATMENT USING 2D-SWE OF THE LIVER AND SPLEEN.
- Author
-
Musa, Adelina Mihaela, Musa, Mihai, Tieranu, Cristian George, Olteanu, Andrei, and Saftoiu, Adrian
- Subjects
- *
ESOPHAGEAL varices , *SPLEEN , *LIVER , *CIRRHOSIS of the liver , *SHEAR waves - Abstract
Aims. Among the non-invasive methods of evaluation in cirrhotic patients, the shear wave elastography (2D-SWE) method has been used to quantify the stiffness in chronic liver disease with good accuracy. Several studies have shown that each complication of cirrhosis is associated with a certain amount of liver stiffness. The objective of the study we performed was to quantify the use of elastography (liver and spleen) in predicting the risque and the grade of gastro-esophageal varices in patients diagnosed with hepatic cirrhosis. Methods. We used the GE Logiq E9/E10 ultrasound system for 34 pacients. We excluded the pacients with liver neoplasia, infiltrative liver disease, acute virale hepatitis and obstructive cholestasis. The value cutt-off used for liver stiffness was >11.88 kPa (>1.99 m/s), correspondent for F4 Metavir. The procedure was realized after 4 hours of fasting, intercostal at 1.5-2 cm below liver and spleen capsule avoiding vessels. Six measurements were obtained for each patient. The results were compared with upper digestive endoscopy. Results. We performed liver elastography for 34 patients known with liver cirrhosis, 94.2% due to ethanol consumption, of which 29.4% (n:10) were female and 70.5% (n:24) were male. We compared the degree of esophageal varices with the value of elastography. Elastography can differentiate patients without esophageal varices from patients with moderate (p value=0.072) or large esophageal varices (p value=0.013), but it cannot differentiate between patients without esophageal varices and those with small esophageal varice (p value=0.8249). However, there was a lack of correlation between the elastographic values of the spleen and the degree of esophageal varices (p value= 0.5860). Conclusions. The results obtained are indicating that 2D-SWE of the liver can be used for ruling-out varices needing treatment in patients with cACLD, knowing that the presence of varices and especially of varices needing treatment indicates distinct prognostic stages in patients with compensated ACLD (cACLD). [ABSTRACT FROM AUTHOR]
- Published
- 2023
22. PANCREATIC CANCER STEM CELLS EXPRESSION ON ENDOSCOPIC ULTRASOUND FINE NEEDLE BIOPSY PANCREATIC DUCTAL ADENOCARCINOMA SAMPLES.
- Author
-
Ungureanu, Bogdan Silviu, Gheonea, Dan Ionut, Georgescu, Claudia Valentina, Pirici, Daniel, Bitina, Luiza, Cazacu, Irina Mihaela, and Saftoiu, Adrian
- Subjects
- *
CANCER stem cells , *PANCREATIC duct , *ENDOSCOPIC ultrasonography , *NEEDLE biopsy , *PANCREATIC cancer , *PANCREATIC tumors , *PANCREATIC intraepithelial neoplasia - Abstract
Pancreatic ductal adenocarcinoma (PDAC) is characterized by an intense fibrosis which enhances the growth of tumor cells and drives an epithelialmesenchymal transition. The consequence is the uncontrolled proliferation of cancer cells, including pancreatic cancer stem cells (PCSC), which can enhance the metastatic potential. Objective. The aim of this study is to assess the expression of pancreatic cancer stem cells, on pancreatic endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) specimens. Material and Methods. A total of 21 patients diagnosed with PDAC after EUS-FNB within the Research Center of Gastroenterology and Hepatology of Craiova, were included in the study, and the samples were sent for immunohistochemical assessment. Anti-Human CD 24 (policlonal, Abcam, ab 199140) and EpCAm (Epr 20532-225, Rb monoclonal, Abcam, ab 223582) were used. Results. All cases were positive for CD24 and EpCAM. In NOS ductal adenocarcinomas, CD24 immunomarking was heterogeneous, with variable intensity and a variable number of positive cells within the same case. Well and moderately differentiated adenocarcinomas that formed tubular or papillary structures showed a higher intensity CD24 expression compared to poorly differentiated or undifferentiated adenocarcinomas. EpCam showed a stronger immunolabeling intensity in the analyzed samples. PDAC EpCam expression was of moderate and high intensity and with a heterogeneous appearance in NOS G1 adenocarcinomas, but the intensity of the immunomarking tended to decrease with increasing histological grade. Conclusions. EUS-FNB PCSC immunohistochemistry is feasible. At the subcellular level, the basolateral membranous and cytoplasmic staining of EpCam in PDAC could be correlated with tumor invasion and possibly with the unfavorable evolution of this type of carcinoma, while CD24 frequently presents an apical immunostaining pattern and could suggest the presence of an epithelial-type phenotype of tumor cells, with a lower potential for invasiveness and metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
23. Common variants in glyoxalase I do not increase chronic pancreatitis risk.
- Author
-
Kaune, Tom, Hollenbach, Marcus, Keil, Bettina, Chen, Jian-Min, Masson, Emmanuelle, Becker, Carla, Damm, Marko, Ruffert, Claudia, Grützmann, Robert, Hoffmeister, Albrecht, te Morsche, Rene H. M., Cavestro, Giulia Martina, Zuppardo, Raffaella Alessia, Saftoiu, Adrian, Malecka-Panas, Ewa, Głuszek, Stanislaw, Bugert, Peter, Lerch, Markus M., Weiss, Frank Ulrich, and Zou, Wen-Bin
- Subjects
- *
CHRONIC pancreatitis , *LOGISTIC regression analysis , *GLYOXALASE , *REACTIVE oxygen species , *OXIDATIVE stress - Abstract
Chronic pancreatitis (CP) may be caused by oxidative stress. An important source of reactive oxygen species (ROS) is the methylglyoxal-derived formation of advanced glycation endproducts (AGE). Methylglyoxal is detoxified by Glyoxalase I (GLO1). A reduction in GLO1 activity results in increased ROS. Single nucleotide polymorphisms (SNPs) of GLO1 have been linked to various inflammatory diseases. Here, we analyzed whether common GLO1 variants are associated with alcoholic (ACP) and non-alcoholic CP (NACP). Using melting curve analysis, we genotyped a screening cohort of 223 ACP, 218 NACP patients, and 328 controls for 11 tagging SNPs defined by the SNPinfo LD TAG SNP Selection tool and the functionally relevant variant rs4746. For selected variants the cohorts were extended to up to 1,441 patient samples. In the ACP cohort, comparison of genotypes for rs1937780 between patients and controls displayed an ambiguous result in the screening cohort (p = 0.08). However, in the extended cohort of 1,441 patients no statistically significant association was found for the comparison of genotypes (p = 0.11), nor in logistic regression analysis (p = 0.214, OR 1.072, 95% CI 0.961–1.196). In the NACP screening cohort SNPs rs937662, rs1699012, and rs4746 displayed an ambiguous result when patients were compared to controls in the recessive or dominant model (p = 0.08, 0.08, and 0.07, respectively). Again, these associations were not confirmed in the extended cohorts (rs937662, dominant model: p = 0.07, logistic regression: p = 0.07, OR 1.207, 95% CI 0.985–1.480) or in the replication cohorts for rs4746 (Germany, p = 0.42, OR 1.080, 95% CI 0.673–1.124; France, p = 0.19, OR 0.90, 95% CI 0.76–1.06; China, p = 0.24, OR 1.18, 95% CI 0.90–1.54) and rs1699012 (Germany, Munich; p = 0.279, OR 0.903, 95% CI 0.750–1.087). Common GLO1 variants do not increase chronic pancreatitis risk. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
24. Malignant Transformation of Ectopic Pancreas.
- Author
-
Cazacu, Irina M., Luzuriaga Chavez, Adriana Alexandra, Nogueras Gonzalez, Graciela M., Saftoiu, Adrian, and Bhutani, Manoop S.
- Subjects
- *
PANCREAS , *ECTOPIC tissue , *PANCREATIC cancer , *SYMPTOMS , *LITERATURE reviews - Abstract
Malignant transformation of ectopic pancreas tissue is a diagnostic challenge as clinical symptoms and radiographic features of these tumors are non-specific. Given the rarity of these lesions, it is usually neither suspected nor included in the diagnostic workup of different tumors. We conducted a comprehensive literature review regarding malignancy arising from ectopic pancreas for a better understanding of its frequency, clinicopathological features, and prognosis. A literature search was performed in three major databases: PubMed, Cochrane, and Web of Science. Fifty-four well-documented cases of malignant ectopic pancreas were identified in the published literature. Our analysis provided the following observations: (1) there was a slight predominance of males over females; (2) most patients with malignant transformation of ectopic pancreas were middle-aged; (3) most commonly, the tumor was located in the stomach; (4) most tumors were adenocarcinomas; (5) most frequently, the malignancy arose within a type I heterotopia according to Heinrich classification; (6) macroscopically, a subepithelial-like appearance was most frequently observed; and (7) improved prognosis for ectopic pancreatic malignancies in comparison with reported survival data for orthotopic pancreatic cancer. Even if the majority of cases of ectopic pancreas are incidental findings and malignant transformation is a rare event, pancreatic heterotopy should be considered as a source of potentially malignant lesions. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
25. Medical Student Ultrasound Education: A WFUMB Position Paper, Part I.
- Author
-
Dietrich, Christoph F., Hoffmann, Beatrice, Abramowicz, Jacques, Badea, Radu, Braden, Barbara, Cantisani, Vito, Chammas, Maria C., Cui, Xin-Wu, Dong, Yi, Gilja, Odd Helge, Hari, Roman, Nisenbaum, Harvey, Nicholls, Delwyn, Nolsøe, Christian Pállson, Nürnberg, Dieter, Prosch, Helmut, Radzina, Maija, Recker, Florian, Sachs, Alexander, and Saftoiu, Adrian
- Subjects
- *
MEDICAL students , *ULTRASONIC imaging , *MEDICAL education , *CLINICAL indications , *BIOMEDICAL transducers - Abstract
The introduction of ultrasound into medical student education is well underway in many locations around the world, but is still in its infancy or has yet to begin in others. Proper incorporation of ultrasound education into medical training requires planning and resources, both capital and human. In this article, we discuss the state of the art of ultrasound in medical education throughout the world, as well as various methodologies utilized to improve student education and to incorporate ultrasound into every facet of training. Experiences from various educational systems and available evidence regarding the impact of ultrasound education are summarized. Representing multiple societies and specialties throughout the world, we discuss established modern as well as novel education structures and different successful approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
26. Endoscopic ultrasound elastography of small solid pancreatic lesions: a multicenter study.
- Author
-
Ignee, Andre, Dietrich, Christoph F., Ponnudurai, Ryan, Braden, Barbara, Atkinson, Nathan S., Burmester, Eike, Yi Dong, Dong, Yi, Jenssen, Christian, Arcidiacono, Paolo G., Petrone, Maria C., Hocke, Michael, Möller, Kathleen, Saftoiu, Adrian, Will, Uwe, Fusaroli, Pietro, and Iglesias-Garcia, Julio
- Subjects
- *
ELASTOGRAPHY , *ENDOSCOPIC ultrasonography - Abstract
Background: The prevalence of malignancy in patients with small solid pancreatic lesions is low; however, early diagnosis is crucial for successful treatment of these cases. Therefore, a method to reliably distinguish between benign and malignant small solid pancreatic lesions would be highly desirable. We investigated the role of endoscopic ultrasound (EUS) elastography in this setting.Methods: Patients with solid pancreatic lesions ≤ 15 mm in size and a definite diagnosis were included. Lesion stiffness relative to the surrounding pancreatic parenchyma, as qualitatively assessed and documented at the time of EUS elastography, was retrospectively compared with the final diagnosis obtained by fine-needle aspiration/biopsy or surgical resection.Results: 218 patients were analyzed. The average size of the lesions was 11 ± 3 mm; 23 % were ductal adenocarcinoma, 52 % neuroendocrine tumors, 8 % metastases, and 17 % other entities; 66 % of the lesions were benign. On elastography, 50 % of lesions were stiffer than the surrounding pancreatic parenchyma (stiff lesions) and 50 % were less stiff or of similar stiffness (soft lesions). High stiffness of the lesion had a sensitivity of 84 % (95 % confidence interval 73 % - 91 %), specificity of 67 % (58 % - 74 %), positive predictive value (PPV) of 56 % (50 % - 62 %), and negative predictive value (NPV) of 89 % (83 % - 93 %) for the diagnosis of malignancy. For the diagnosis of pancreatic ductal adenocarcinoma, the sensitivity, specificity, PPV, and NPV were 96 % (87 % - 100 %), 64 % (56 % - 71 %), 45 % (40 % - 50 %), and 98 % (93 % - 100 %), respectively.Conclusions: In patients with small solid pancreatic lesions, EUS elastography can rule out malignancy with a high level of certainty if the lesion appears soft. A stiff lesion can be either benign or malignant. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
27. Intraoperative cardiovascular response of natural orifice transluminal endoscopic surgery versus laparoscopy: A comparative animal study.
- Author
-
Patrascu, Stefan, Copaescu, Catalin Andu, Surlin, Valeriu, Ramboiu, Sandu, Dragoescu, Alice Nicoleta, Stanilescu, Sorin, Cristian, Dan, Ungureanu, Bogdan Silviu, Burtea, Daniela Elena, Patrascu, Ana Maria, Turcu, Florin, and Saftoiu, Adrian
- Subjects
- *
CARDIOVASCULAR disease treatment , *ENDOSCOPIC surgery , *GASTRIC bypass , *HEMODYNAMICS , *INTRAOPERATIVE care , *TRANSLUMINAL angioplasty - Abstract
Background: Natural orifice transluminal endoscopic surgery (NOTES) emerged as a new alternative method in minimally invasive techniques. Although a very small number of studies have compared the physiologic response in NOTES to laparoscopy, the results remain controversial. Aim: This experimental animal study aims to evaluate the intraoperative cardiovascular and respiratory effects of pure transluminal natural orifice surgery and conventional laparoscopy. Materials and Methods: Twenty female pigs (Sus scrofa domesticus) equally divided into two study groups were assigned to either pure natural orifice transluminal endoscopic techniques (Group 1) or conventional laparoscopic surgery (Group 2) and monitored intraoperatively in terms of heart rate (HR), systolic blood pressure (SBP) and O2 saturation (SpO2) for 1 h. Both groups underwent simple surgical procedures such as gastrojejunostomy, oophorectomy and adnexectomy. Results: All procedures were successfully completed. The findings indicated statistically significant differences between SBP (P = 0.0065) and SpO2 (P = 0.027) in the two groups at the beginning of the interventions. HR showed significant differences during the last 20 min of the interventions (min 40 and 45; P < 0.001). For the whole procedure (from the beginning of the intervention to 60 min interval), HR, SBP and SpO2 values showed no statistical difference. Conclusions: Although significant differences in terms of HR, mean blood pressure and SpO2 were noted at specific intervals during surgery, no real variance of the cardiovascular parameters was observed when considering the entire procedure. Therefore, NOTES seems to be a safe approach with minimally intraoperative cardiovascular and respiratory implications. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
28. UNUSUAL CAUSE OF UPPER GASTROINTESTINAL BLEEDING.
- Author
-
Musa, Mihai, Musa, Adelina, Olteanu, Andrei Ovidiu, Tieranu, Cristian George, and Saftoiu, Adrian
- Subjects
- *
GASTROINTESTINAL hemorrhage , *VENA cava inferior , *ISCHEMIC colitis , *HYPERTENSION , *GASTRIC mucosa , *ALIMENTARY canal - Abstract
Aims. An 84-year-old patient with a history of high blood pressure presented to the emergency room with lower abdominal pain and haematochezia. Methods. Clinical:hemodynamically stable. Biological: WBC 32700/microL, Hb=8.1 g/dL, PLT = 321 000/microL, INR=1.23, CRP = 292 mg/L. CTscan: no contrast extravasation in the digestive tract, infrarenal aortic aneurysm (130 mm cranio-caudal), with parietal thrombus plus a retroaortic abscess with stenosis of the inferior vena cava. Vascular surgery consultation: no surgical indication ->admission to the gastroenterology department. Emergency upper GI endoscopy: adherent clot in the fornix, stasis fluid. 60 cm rectosigmoidoscopy: mucosal lesions suggestive of ischemic colitis. Reevaluation after 12 h: WBC = 26 000/microL, hemoglobin = 7.1 g/dL Results. Re-evaluation of the CT-scan: suspicion of an aorto-duodenal fistula. Second upper GI endoscopy: gastric mucosa, bulb and D2 lined with fresh blood. On withdrawal, an infrapapillary lesion suggestive for an aortoenteric fistula. Duodenoscopesecond look:an erosion with a diameter of 10 mm with a deep punctate hole: most likely aortoenteric fistula. The patient was transferred to cardio-vascular surgery: double-layer duodenorrhaphy and aorto-aortic interposition of a silver Dacron prosthesis were done. Conclusion. The particularity of the case was represented by the rare cause of haemorrhage with difficult diagnosis. The approach and treatment required a multidisciplinary team and a good collaboration. The patient was discharged after 17 days with a good general condition. [ABSTRACT FROM AUTHOR]
- Published
- 2023
29. THE IMPACT OF COVID-19 PANDEMIC ON VARICEAL UPPER GASTROINTESTINAL BLEEDING: OUTCOMES IN A ROMANIAN EMERGENCY HOSPITAL.
- Author
-
Musa, Mihai, Musa, Adelina Mihaela, Grozavu, Daniela, Gherghe, Cristian, Moisa, Emanuel, Tieranu, Cristian George, Olteanu, Andrei Ovidiu, Ionescu, Elena Mirela, and Saftoiu, Adrian
- Subjects
- *
COVID-19 pandemic , *HOSPITAL emergency services , *GASTROINTESTINAL hemorrhage , *ROMANIANS - Abstract
Aims. Variceal bleeding is a common and severe cause of hospitalization in cirrhotic patients. We analyzed how the COVID-19 waves modified the outcome of the patients compared to COVID-19 extra-wave intervals. Methods. We retrospectively included all patients hospitalized between March 2020 and December 2021 for variceal bleeding. They were separated in 2 categories: hospitalizations during COVID-19 extrawaves period and the COVID-19 waves. Variables like sex, age, hemoglobin at presentation, endoscopic timing, hemostatic methods, transfusion necessity, duration of hospitalization and mortality were analyzed. Results. Out of 76 patients (2020-2021), 20patients were hospitalized during the COVID-19 waves. The median age did not differ significantly across groups (61 years [IQR: 52-65] vs 58years [IQR: 44-64]), 59 patients being male and 17 being female. The number of admissions for variceal bleeding and gastroscopy requirement and timing were similar regardless of the studied period (p > 0.05). Median hemoglobin admission values were significantly lower in the following subgroups: patients in whom gastroscopy was performed in less than 6 hours or more than 12 hours (p = 0.045) and patients requiring PRBC transfusion (p = 0.018). There were also no differences in duration of hospitalization and mortality between the two studied periods (p>0.05). Conclusions. The number of patients remained relatively constant in both periods. We found no differences in the management and outcomes of patients with variceal bleeding throughout the COVID pandemic. Our results might be influenced by the low number of patients and need confirmation on larger cohorts. [ABSTRACT FROM AUTHOR]
- Published
- 2023
30. DIFFERENTIATING SOLID PANCREATIC LESIONS: THE CONTRIBUTION OF EUS-FNB WITH CONTRAST-ENHANCED IMAGING.
- Author
-
Harbiyeli, Irina Florina Cherciu, Georgescu, Albert, Georges, Fadel, Fieraru, Alexandra Adriana, Burtea, Elena Daniela, and Saftoiu, Adrian
- Subjects
- *
CONTRAST-enhanced ultrasound , *ENDOSCOPIC ultrasonography , *ULTRASONIC imaging , *PANCREAS , *NEEDLE biopsy , *PANCREATIC duct , *MUCINOUS adenocarcinoma - Abstract
Endoscopic ultrasound tissue acquisition, in the form of fine needle biopsy (EUS-FNB) was designed to provide a proper quantitative sample for determining the histologic architecture and further immunohistochemical staining. This study aimed to investigate the contribution of associating contrast-enhanced ultrasound imaging (CEUS) with EUS-FNB for differentiating solid pancreatic lesions without on-site cytopathology. Patients from our institutional database who underwent CE-FNB-EUS for the evaluation of a solid pancreatic lesion were retrieved. Micro vascularization of the tumor was evaluated over 2 min during CEUS after intravenous injection of 4.8 mL SonoVue and was classified as hypervascular, isovascular or hypovascular during both arterial and venous phase. Final diagnosis was based on histopathology of surgical specimens or EUS-guided tissue acquisition and clinical follow-up. Our retrospective study (2018-2021) enrolled 46 patients with a mean age of 58, female to male ratio 1:2, mass location: 2/3 head, 1/3 body and tail of the pancreas, average mass size 3.5 cm, mean number of needle passes (fanning technique): 2. Final pathology revealed pancreatic ductal adenocarcinoma-PDAC (26), mass-forming pancreatitis-MFP (10), pancreatic neuroendocrine tumors-pNETs (4), undifferentiated carcinoma (3), mucinous carcinoma (1), pancreatic metastasis (1). Hypo-enhancement was noted in 67% of the patient, and the final diagnosis was malignancy in all those cases. Regarding the enhancement patterns: hypovascularity in both arterial and venous phase was associated to PDAC, hypervascularity or isovascularity in both phases were associated to either MFP or NETs, while the carcinomas were hypervascular. A heterogeneous appearance with non-enhancing areas was noted in a small percentage of the hypo-enhancing lesions and it might suggest necrosis. The overall diagnostic accuracy was 91%. CE-EUS allows detailed visualization of the dynamic enhancement patterns hence it helps to identify the target of EUS-FNB among different pathological areas of the lesions. CE-FNB-EUS can be used for the differential diagnosis and adequate sampling of solid pancreatic lesions without on-site cytopathology. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Modern Endoscopic Imaging in Diagnosis and Surveillance of Inflammatory Bowel Disease Patients.
- Author
-
Hundorfean, Gheorghe, Pereira, Stephen P., Karstensen, John G., Vilmann, Peter, and Saftoiu, Adrian
- Subjects
- *
INFLAMMATORY bowel diseases , *GASTROINTESTINAL diseases , *BIOFLUORESCENCE , *LASER endoscopy , *INFLAMMATION , *PATIENTS - Abstract
Endoscopy remains the most important diagnostic and monitoring modality in the management of inflammatory bowel disease. Advances in imaging have progressively added new tools into the armamentarium of endoscopists with the goal of more accurate, sensitive, and accessible visual diagnoses for the benefit of patients with gastrointestinal diseases. Here, we review the relevant literature regarding commonly used endoscopic techniques (dye-based and digital chromoendoscopy, high-definition endoscopy, capsule endoscopy, and endosonography), as well as advanced and experimental technologies (full-spectrum endoscopy, endocytoscopy, autofluorescence, laser endoscopy, and endomicroscopy, including molecular imaging), applicable to inflammatory bowel diseases and emerging for implementation into everyday practice. Additionally, we discuss future directions and techniques as candidates for a superior inflammation imaging in the diagnosis and prediction of therapeutic response. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
32. Author's response.
- Author
-
Gheonea, Ioana-Andreea, Sandulescu, Larisa, and Saftoiu, Adrian
- Published
- 2014
- Full Text
- View/download PDF
33. Contrast enhanced ultrasound and magnetic resonance imaging for hepatoma diagnosis.
- Author
-
Gheonea, Ioana-Andreea, Sandulescu, Larisa, and Saftoiu, Adrian
- Subjects
- *
MAGNETIC resonance imaging , *HEPATOCELLULAR carcinoma , *GENE therapy - Abstract
A response from the author of the article related to ultrasound and magnetic resonance imaging for hepatoma diagnosis in previous issue is presented.
- Published
- 2014
- Full Text
- View/download PDF
34. European Society of Gastrointestinal Endoscopy - Establishing the key unanswered research questions within gastrointestinal endoscopy.
- Author
-
Rees, Colin J., Wee Sing Ngu, Meisner, Søren, Spada, Cristiano, Hassan, Cesare, Valori, Roland, Hucl, Tomas, Le Moine, Olivier, Domagk, Dirk, Bretthauer, Michael, Rutter, Matthew D., Aabakken, Lars, Regula, Jaroslaw, Kaminski, Michal F., Ponchon, Thierry, Siersema, Peter D., Bisschops, Raf, Saftoiu, Adrian, Dekker, Evelien, and Fockens, Paul
- Subjects
- *
GASTROINTESTINAL diseases , *ENDOSCOPY , *DELPHI method , *QUESTIONNAIRES , *SCIENTIFIC community , *MEDICAL societies , *PUBLISHING , *QUALITY assurance , *RESEARCH , *TIME , *DIGESTIVE system endoscopic surgery , *STANDARDS ,DIAGNOSIS of digestive system diseases - Abstract
Background and study aim: Gastrointestinal endoscopy is a rapidly evolving research field. The European Society of Gastrointestinal Endoscopy (ESGE) plays a key role in shaping opinion and endoscopy activity throughout Europe and further afield. Establishing key unanswered questions within the field of endoscopy and prioritizing those that are important enables researchers and funders to appropriately allocate resources. Methods: Over 2 years, the ESGE Research Committee gathered information on research priorities and refined them through a modified Delphi approach. Consultations were held with the ESGE Governing Board and Quality Improvement Committee to identify important unanswered questions. Research workshops were held at the 21st United European Gastroenterology Week. Research questions were refined by the ESGE Research Committee and Governing Board, compiled into an online survey, and distributed to all ESGE members, who were invited to rank each question by priority. Results: The final questionnaire yielded 291 responses from over 60 countries. The three countries with the highest response rates were Spain, Italy, and United Kingdom. Most responders were from teaching hospitals (62 %) and were specialist endoscopists (51 %). Responses were analyzed with weighted rankings, resulting in prioritization of 26 key unanswered questions. The top ranked generic questions were: 1) How do we define the correct surveillance interval following endoscopic diagnosis? 2) How do we correctly utilize advanced endoscopic imaging? 3) What are the best markers of endoscopy quality? Conclusion: Following this comprehensive process, the ESGE has identified and ranked the key unanswered questions within the field of gastrointestinal endoscopy. Researchers, funders, and journals should prioritize studies that seek to answer these important questions. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
35. CONTRAST-ENHANCED ULRASONOGRAPHY IN DIAGNOSIS AND FOLLOW UP OF PANCREATIC PSEUDOANEURYSM – CASE REPORT.
- Author
-
Iordache, Sevastita, Gulie, Laurentiu, Crasan, Andreea, Constantin, Cristian, Sandulescu, Larisa, Cazacu, Sergiu, and Saftoiu, Adrian
- Subjects
- *
FALSE aneurysms , *CONTRAST-enhanced ultrasound , *SINUS of valsalva , *CHRONIC pancreatitis , *MESENTERIC artery , *COMPUTED tomography - Abstract
Pancreatic pseudoaneurysm is a rare condition usually associated with pancreatic disorders: pancreatitis, neoplasm, or cystic lesions of the pancreas. Almost 10% of patients with chronic pancreatitis develop during disease progression a pseudoaneurysm. Usually appears secondary to a communication between a pseudocyst and a nearby artery. We present the case of a patient with chronic pancreatitis, with recurrent exacerbations and pseudocyst of 4 cm diameter located posterior of the pancreatic body. The conventional abdominal ultrasound revealed the hypoechoic mass, suspected at that moment for complicated pseudocyst. Contrast enhanced ultrasound revealed a hypervascular area 1.5 cm diameter inside de cystic lesion, suspected of pseudoaneurysm. The digital arteriography confirms the diagnosis of pseudoaneurysm originated form first branch of superior mesenteric artery (SMA), but without treatment options at that time. EUS confirmed the diagnosis of chronic pancreatitis and pancreatic pseudoaneurysm, no other suspected masses were detected. Two weeks later, the patient presented again in the emergency room for severe abdominal pain, laboratory tests showing an increased serum amylase and lipase level. Ultrasound revealed the same lesion of 5 cm diameter posterior of the body, with color Doppler suggestive of pseudoaneurysm, this time 3 cm in diameter. During hospitalization patient presented upper GI bleeding without any lesion found at upper GI endoscopy. Further emergency arteriography was performed, with coils angioembolization of the lesion, without complications. CT scan and ultrasound performed at one week confirm the successful treatment of pseudoaneurysm. The review of the literature in the field of pancreatic pseudoaneurysm revealed isolated cases reports, few data series. Although the role of CEUS in pancreatic disorders is largely discussed in the literature, in pancreatic pseudoaneurysm, due to the rarity of the cases, is not well standardized. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
36. AN UNUSUAL CEUS FINDING IN A PATIENT WITH CARCINOID SYNDROME.
- Author
-
Gheorghe, Elena Codruta, Stoica, Maria, Dimitriu, Anca, Burtea, Daniela Elena, Bejinariu, Nona, and Saftoiu, Adrian
- Subjects
- *
ENDOSCOPIC ultrasonography , *CARCINOID , *NEUROENDOCRINE tumors , *SYNDROMES , *CONTRAST-enhanced ultrasound , *NEEDLE biopsy - Abstract
Midgut carcinoid tumors are rare neuroendocrine tumors that can spread to the intestinal mesentery. Although the mesenteric tumor is usually the first finding due to abdominal discomfort, some patients with hepatic metastases might experience symptoms of carcinoid syndrome. We present the case of a 74 year old male with weight loss, diffuse abdominal pain, facial flushing and diarrhea for about 2 months who was diagnosed with an ill-defined mesenteric mass andhepatic, pulmonary and lymph node metastatic lesions. To better characterize the hepatic lesions, contrast-enhanced ultrasonography (CEUS) was performed. It revealed hypervascular lesions in the arterial phase and complete washout during the portal phase, suggestive for liver metastases. Surprisingly, a reflux of contrast into the inferior vena cava was also noticed in the arterial phase. This can be an uncommon finding on contrast-enhanced ultrasound (CEUS) or computed tomography (CECT) that may indicate right-sided heart disease or high flow contrast injection rates. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) confirmed the diagnosis of peripancreaticlymph node and liver metastases of neuroendocrine tumor. This case report illustrates the role of ultrasound imaging for the diagnosis of rare tumors such as carcinoid tumors and also a peculiar finding on liver CEUS. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
37. HOW TO IMPROVE THE CONTRAST ENHANCED ULTRASOUND (CEUS) LI-RADS ALGORITHM FOR THE DIAGNOSIS OF DEFINITE HEPATOCELLULAR CARCINOMA: THE ROLE OF COMBINATION OF LR- 4 AND LR-5.
- Author
-
Sandulescu, Larisa, Ciocalteu, Adriana, Sandulescu, Sarmis, Ciurea, Ana- Maria, Saftoiu, Adrian, and Rogoveanu, Ion
- Subjects
- *
CONTRAST-enhanced ultrasound , *HEPATOCELLULAR carcinoma , *DIAGNOSIS , *DIFFERENTIAL diagnosis , *CIRRHOSIS of the liver , *ALGORITHMS - Abstract
CEUS has increased the capability of ultrasonography for the detection of focal liver lesions (FLL). The differential diagnosis between hepatocellular carcinoma (HCC) and other malignant tumors may be limited by similarities in the appearance of CEUS. The aim of this study was to evaluate the role of combination of LR-4 and LR-5 by adding ancillary features (AFs) in the CEUS LI-RADS v2017 algorithm for the diagnosis of definite HCC. This retrospective single- center study included 143 patients with 191 FLL detected by abdominal ultrasound from a total of 823 consecutive patients. The risk factors were liver cirrhosis of any etiology and non-cirrhotic HBV patients. Diagnosis was established either through histopathology or based on CT/MRI scan. CEUS recordings were assessed by an EFSUMB level 3 sonographer, with more than 10 years experience in CEUS and who was blinded to clinical data and to the final diagnosis. All lesions have been categorized according to the CEUS LI-RADS® described by The American College of Radiology scheme. The AFs were taken into account. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy were calculated. PPV for primitive malignancy (LR-4 + LR-5) was 95.7% (95CI%: 90.7–98%), with 88.07% sensitivity, 89.3% specificity and 88.4% accuracy for HCC (95CI%: 82.8–92.6%). LR4 + LR5 had 81.8% sensitivity for HCCs over 2 cm (n = 127), and 78.57% sensitivity for HCCs less than 2 cm (n = 14). Both sensitivity and accuracy of LR-4 + LR-5 for the diagnosis of definite HCC considerably raised to 88.07% and 88.4%, unlike the sensitivity and accuracy for LR-5 of only 60.45% and 69%, respectively. NPV also improved (73.4% vs. 46.6%), while similar high PPVs (95.7% vs. 96.2%) and quite similar specificity (89.3% vs. 93.6%) were maintained. Higher sensitivity than estimated for the diagnosis of HCCs smaller than 2 cm was achieved for CEUS LR-4 and LR-5. The use of AFs might improve the overarching goal of CEUS LR-5 + LR-4 diagnosis of high specificity for HCC and exclusion of non-HCC malignancy, despite the size of the lesion. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
38. THE ROLE OF DYNAMIC CONTRAST HARMONIC IMAGING ENDOSCOPIC ULTRASOUND (CHI-EUS) AND CD105 AND CD31 IMMUNOSTAINING IN TUMOR ANGIOGENESIS ASSESSMENT ON PATIENTS WITH GASTRIC CANCER – A FEASIBILITY STUDY.
- Author
-
Sacerdotianu, Victor Mihai, Ungureanu, Bogdan Silviu, Iordache, Sevastita, Rogoveanu, Ion, Saftoiu, Adrian, and Ciurea, Tudorel
- Subjects
- *
ENDOSCOPIC ultrasonography , *STOMACH cancer , *ULTRASONIC imaging , *CANCER patients , *NEOVASCULARIZATION , *STATISTICAL correlation - Abstract
Angiogenesis is a critical process for tumor growth and metastasis, it is now considered an important marker of disease prognosis and sensitivity to anticancer therapy. However, gastric cancer (GC) studies are rather scarce. CHI-EUS was proposed in this study as a useful method to assess GC vascularization patterns. Patients initially diagnosed with GC, only adenocarcinoma type, who subsequently performed CHI-EUS examinations before any treatment decision, were included in this study. Dedicated software named Vuebox (Bracco Imaging S.p.A., Milan, Italy) was used to quantitatively evaluate angiogenesis in the chosen regions of interest (ROI). As a result, this software generated automatically parameters derived from time-intensity curve (TIC) like peak enhancement (PE), rise time (RT), time to peak (TTP), wash in perfusion index (WiPI), ROI area, and others were compared to immunohistopathological data. CD105 and CD31 immunostaining was performed to calculate the vascular diameter (vd) and the microvascular density (MVD). The final results were compared with CHI-EUS parameters. A total of eighty CHI-EUS video sequences were assessed. Multiple high statistical correlations (p<0.05) were highlighted between TIC analysis parameters, MVD, and vd CD31. Also, strong correlations were found between tumor grade and CHI-EUS parameters, p<0.005. Differences in TIC parameters and immunohistochemical markers between the group of patients without (M0) versus the group with (M1) metastasis were noted. Our study demonstrated that GC angiogenesis assessed by CHI-EUS was a feasible method and may be considered for future studies based on TIC analysis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
39. Endoscopic ultrasound guided injection of iron oxide magnetic nanoparticles for liver and pancreas: a feasibility study in pigs.
- Author
-
Ungureanu, Bogdan Silviu, Pirici, Daniel, Mărgăritescu, Claudiu, Gheonea, Ioana Andreea, Trincu, Florian Nicu, Fifere, Adrian, Săftoiu, Adrian, Margaritescu, Claudiu, and Saftoiu, Adrian
- Subjects
- *
ENDOSCOPY , *ENDOSCOPIC ultrasonography , *DIAGNOSTIC ultrasonic imaging , *PANCREATIC cancer diagnosis , *LIVER cancer - Abstract
Aims: Pancreatic cancer and hepatocellular carcinoma are two of the most aggressive types of cancer with limited therapeutic options in stages of advanced disease. Our objective is to assess the safety and feasibility of injecting iron oxide nanoparticles (IONs) via endoscopic ultrasound (EUS)-guidance, both systemically and locally in the liver and pancreas in order to study new potential therapies for liver and pancreatic tumors.Material and Methods: Six domestic pigs were used for our study design, and divided into three groups: two were injected in the portal vein, and other four were subjected to local exposure of IONs in the liver and pancreas, two each. The pigs were on a 7 days follow-up and necropsy was performed with their organs harvested. A 3T MRI scan was also performed.Results: All animals underwent an endoscopic ultrasound fine needle injection (EUS-FNI) procedure without any complications. EUS-FNI procedure had an average time of 5 minutes and 21 seconds and consisted of 2 ml of ION injection. No perforations and no risk of potential bleeding were recorded. Macroscopic changes were observed only after pancreatic EUS-FNI. A significant amount of IONs was observed in the liver after local injection and after vascular EUS-FNI. The imaging results were confirmed by pathological examination with most of the IONs accumulated in Ito-like cells, Kupfer cells, and sinusoids.Conclusions: IONs have been widely studied for both diagnostic and therapeutic purposes. Their injection through EUS-guidance may develop new diagnosis strategies as well as curative or palliative therapies in pancreatic and liver tumors. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
40. Clinical impact of EUS elastography followed by contrast-enhanced EUS in patients with focal pancreatic masses and negative EUS-guided FNA.
- Author
-
Iordache, Sevastiţa, Ionuţ Costache, Mădălin, Popescu, Carmen Florina, Streba, Costin-Teodor, Cazacu, Sergiu, Săftoiu, Adrian, Iordache, Sevastita, Costache, Madalin Ionut, Saftoiu, Adrian, and Costache, Mădălin Ionuţ
- Subjects
- *
NEEDLE biopsy , *ELASTOGRAPHY , *PANCREATIC cancer diagnosis , *CELLULAR pathology , *CANCER diagnosis , *COMPARATIVE studies , *DIAGNOSTIC errors , *DIAGNOSTIC imaging , *RESEARCH methodology , *MEDICAL cooperation , *PANCREATIC tumors , *PHOSPHOLIPIDS , *RESEARCH , *SULFUR compounds , *ULTRASONIC imaging , *COMPUTER systems , *EVALUATION research , *RESEARCH bias , *CONTRAST media ,RESEARCH evaluation - Abstract
Aims: It is well known that endoscopic ultrasound guided fine needle aspiration (EUS-FNA) has a high sensitivity (over 85%) and specificity (100%) for diagnosis of pancreatic cancer. The aim of the study was to establish a EUS based clinical diagnostic algorithm in patients with pancreatic masses and negative cytopathology after EUS-FNA, based on previously published results and cut-offs of real-time elastographic (RTE) EUS and contrast-enhanced harmonic (CEH) EUS.Material and Methods: We included in the study a subgroup of 50 consecutive patients with focal pancreatic masses which underwent EUS examinations with negative EUS-FNA. RTE-EUS and CEH-EUS were performed sequentially in all patients. The sensitivity, specificity and accuracy of these methods were calculated separately. A clinical decision algorithm based on elastography followed by CEH was established.Results: For the diagnosis of possible malignancy, the sensitivity, specificity and accuracy of RTE-EUS were: 97.7%, 77.4%, and 84% respectively. CEH-EUS had similar results: 89.5%, 80.7%, and 84%, respectively. In 25 patients with soft/mixed appearance during elastography,sequential assessment using contrast-enhanced EUSwas performed. The specificity of CEH-EUS for detection of chronic pancreatitis in this sub-set of patients was excellent (100%). In other 25 patients with hard appearance in elastography (low strain) CEH-EUS had an excellent specificity (100%) and accuracy (93%) in the detection of pancreatic cancer.Conclusions: The proposed algorithm with sequential use of elastography followed by CEH could be a good clinical tool in the set of patients with negative EUS-FNA results for the differentiation between benign and malignant focal pancreatic masses. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
41. Diagnostic Value of Endoscopic Ultrasound after Neoadjuvant Chemotherapy for Gastric Cancer Restaging: A Meta-Analysis of Diagnostic Test.
- Author
-
Sacerdotianu, Victor Mihai, Ungureanu, Bogdan Silviu, Iordache, Sevastita, Turcu-Stiolica, Adina, Facciorusso, Antonio, Crinò, Stefano Francesco, and Saftoiu, Adrian
- Subjects
- *
ENDOSCOPIC ultrasonography , *NEOADJUVANT chemotherapy , *STOMACH cancer , *CANCER chemotherapy , *DIAGNOSIS methods - Abstract
This study aimed to evaluate the diagnostic value of endoscopic ultrasound (EUS) after neoadjuvant therapy (NT) for gastric cancer restaging by meta-analysis. We conducted a systematic search of studies published on PubMed and Web of Science up to 30th August 2021. Assessing the risk of bias in the included studies was done with the QUADAS-2 tool. We used R and Review Manager 5.4.1 for calculations and statistical analysis. To evaluate the diagnostic value of EUS after NT for gastric cancer restaging, we performed a meta-analysis on six studies, with a total of 283 patients, including true-positive, true-negative, false-positive, and false-negative results for T1-T4, N0. EUS as a diagnostic test for GC patients after chemotherapy has a relatively low DOR for the T2 (3.96) and T4 stages (4.79) and a relatively high partial AUC for the T2 (0.85) and T4 (0.71) stages. Our results reveal that the pooled sensitivity for T stages after chemotherapy is rather low (29–56%), except for the T3 stage (71%). A potential limitation of our study was the small number of included studies, but no significant heterogeneity was found between them. Our meta-analysis concludes that EUS is not recommended or is still under debate for GC restaging after NT. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
42. CD133/CD166/Ki-67 Triple Immunofluorescence Assessment for Putative Cancer Stem Cells in Colon Carcinoma.
- Author
-
Margaritescu, Claudiu, Pirici, Daniel, Cherciu, Irina, Barbalan, Alexandru, Cârtân, Tatiana, and Saftoiu, Adrian
- Subjects
- *
COLON cancer , *STEM cells , *CARCINOMA , *CYTOPLASM , *GASTROINTESTINAL diseases - Abstract
Background & Aims: Colorectal cancer represents the third most common malignancy and the fourth most common cause of cancer death worldwide. The existence of drug-resistant colon cancer stem cells is thought to be one of the most important reasons behind treatment failure in colon cancer, their existence putatively leading to metastasis and recurrences. The aim of our study was to investigate the immunoexpression patterns of CD133 and CD166 in colon carcinoma, both individually and in combination, assessing their significance as prognostic markers. Methods. A total of 45 retrospective colon adenocarcinoma cases were investigated by enzymatic and multiple fluorescence immunohistochemistry for their CD133 and CD166 expression and colocalization. Results. Both CD133 and CD166 were expressed to diffierent extents in all cancer specimens, with a predominant cytoplasmic pattern for CD133 and a more obvious membranous-like pattern for CD166. Overall, when comparing their reactivity for the tumoral tissue, CD166 expression areas seemed to be smaller than those of CD133. However, there was a direct correlation between CD133 and CD166 expression levels throughout the entire spectrum of lesions, with higher values for dysplastic lesions. Colocalization of CD133/CD166 was obvious at the level of cells membranes, with higher coefficients in high grade dysplasia, followed by well and moderate differentiated tumours. Conclusions. CD133/CD166 colocalization is an early event occurring in colon tumorigenesis, with the highest coefficients recorded for patients with high grade dysplasia, followed by well differentiated tumours. Thus, we consider that the coexpression of these two markers could be useful for further prognostic and therapeutically stratification of patients with colon cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
43. Role of Contrast-Enhanced Ultrasonography in Hepatocellular Carcinoma by Using LI-RADS and Ancillary Features: A Single Tertiary Centre Experience.
- Author
-
Ciocalteu, Adriana, Iordache, Sevastita, Cazacu, Sergiu Marian, Urhut, Cristiana Marinela, Sandulescu, Sarmis Marian, Ciurea, Ana-Maria, Saftoiu, Adrian, and Sandulescu, Larisa Daniela
- Subjects
- *
HEPATOCELLULAR carcinoma , *ULTRASONIC imaging , *CONTRAST-enhanced ultrasound , *DISEASE risk factors - Abstract
Clinical utility of ancillary features (AFs) in contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS®) is yet to be established. In this study, we assessed the diagnostic yield of CEUS LI-RADS and AFs in hepatocellular carcinoma (HCC). We retrospectively included patients with risk factors for HCC and newly diagnosed focal liver lesions (FLL). All lesions have been categorized according to the CEUS LI-RADS v2017 by an experienced sonographer blinded to clinical data and to the final diagnosis. From a total of 143 patients with 191 FLL, AFs favoring HCC were observed in 19.8% cases as hypoechoic rim and in 16.7% cases as nodule-in nodule architecture. From the total of 141 HCC cases, 83.6% were correctly classified: 57.4%- LR-5 and 26.2%- LR-4. In 9.21% cases, CEUS indicated LR-M; 2.12% cases- LR-3. The LR-5 category was 96.2% predictive (PPV) of HCC. LR-5 had 60.4% sensitivity and 93.6% specificity. PPV for primitive malignancy (LR-4 + LR-5) was 95.7%, with 88% sensitivity, 89.3% specificity and 88.4% accuracy for HCC. LR-4 category had 94.8% PPV and 26.2% sensitivity. CEUS LR4 + LR5 had 81,8% sensitivity for HCCs over 2 cm and 78.57% sensitivity for smaller HCCs. CEUS LR-5 remains an excellent diagnostic tool for HCC, despite the size of the lesion. The use of AFs might improve the overarching goal of LR-5 + LR-4 diagnosis of high specificity for HCC and exclusion of non-HCC malignancy. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
44. Real-Time Elastography Applications in Liver Pathology between Expectations and Results.
- Author
-
Sandulescu, Larisa, Rogoveanu, Ion, Andreea Gheonea, Ioana, Cazacu, Sergiu, and Saftoiu, Adrian
- Subjects
- *
FIBROSIS , *LYMPH nodes , *LIVER biopsy , *CIRRHOSIS of the liver , *ABDOMINAL wall - Abstract
Realtime elastography has very good results in differentiating tumors of the breast, thyroid, prostate, pancreas and lymph nodes. Because liver biopsy is invasive and has complications, the method has been tried in diffuse or localized liver pathology in the hope of similar results. However, the published studies are isolated and performed on small groups of patients and the working methodology differs from author to author, without a consensus regarding the establishing of the area of interest, the recording and data analysis. The appearance of the elastography software on the convex probe with high penetration, the possibility for elastography to visualize the liver entirely and the development of elastography measurement information programs opened new perspectives in the noninvasive assessment of liver pathology. [ABSTRACT FROM AUTHOR]
- Published
- 2013
45. IRGM gene polymorphisms and risk of gastric cancer.
- Author
-
BURADA, Florin, PLANTINGA, Theo S, IOANA, Mihai, ROSENTUL, Diana, ANGELESCU, Cristina, JOOSTEN, Leo A, NETEA, Mihai G, and SAFTOIU, Adrian
- Subjects
- *
GENETIC polymorphisms , *STOMACH cancer risk factors , *AUTOPHAGY , *GASTRITIS , *POLYMERASE chain reaction , *CONFIDENCE intervals , *ALLELES , *DISEASE risk factors - Abstract
OBJECTIVE: The study aimed to assess the possible association of polymorphisms in the autophagy gene IRGM (rs13361189 and rs4958847) with the risk of gastric cancer. METHODS: A total of 102 patients with gastric adenocarcinoma, 52 with chronic gastritis and 351 healthy controls were included in this study. IRGM allelic variants were genotyped by quantitative real-time polymerase chain reaction. The association between polymorphisms and gastric cancer risk was estimated by odds ratios (OR) and 95% confidence interval (CI). RESULTS: A significant difference was found for rs4958847 A allele. Carriers of the A allele were protected against gastric cancer (OR = 0.58, 95% CI 0.35-0.97, P = 0.038). Moreover, the presence of this allele seems to play an important role in decreasing the risk for the intestinal type of gastric cancer (OR = 0.47, 95% CI 0.23-0.94, P = 0.03). In contrast, the rs13361189 IRGM polymorphism was not associated with susceptibility to gastric cancer. None of the targeted polymorphisms were associated with chronic gastritis. CONCLUSION: IRGM rs4958847 polymorphism influences susceptibility to gastric cancer, mainly for the intestinal type. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
46. Hybrid ultrasound imaging techniques (fusion imaging).
- Author
-
Sandulescu, Daniela Larisa, Dumitrescu, Daniela, Rogoveanu, Ion, and Saftoiu, Adrian
- Subjects
- *
ULTRASONIC imaging of cancer , *NEOVASCULARIZATION inhibitors , *POSITRON emission tomography , *LIVER cancer , *RADIATION exposure - Abstract
Visualization of tumor angiogenesis can facilitate noninvasive evaluation of tumor vascular characteristics to supplement the conventional diagnostic imaging goals of depicting tumor location, size, and morphology. Hybrid imaging techniques combine anatomic [ultrasound, computed tomography (CT), and/or magnetic resonance imaging (MRI)] and molecular (single photon emission CT and positron emission tomography) imaging modalities. One example is real-time virtual sonography, which combines ultrasound (grayscale, colour Doppler, or dynamic contrast harmonic imaging) with contrast-enhanced CT/MRI. The benefits of fusion imaging include an increased diagnostic confidence, direct comparison of the lesions using different imaging modalities, more precise monitoring of interventional procedures, and reduced radiation exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
47. Hybrid ultrasound imaging techniques (fusion imaging).
- Author
-
Sandulescu, Daniela Larisa, Dumitrescu, Daniela, Rogoveanu, Ion, and Saftoiu, Adrian
- Subjects
- *
ULTRASONIC imaging , *NEOVASCULARIZATION inhibitors , *DIAGNOSTIC imaging , *TUMOR blood vessels , *COMPUTED tomography , *SINGLE photon emission computerized tomography centers - Abstract
Visualization of tumor angiogenesis can facilitate noninvasive evaluation of tumor vascular characteristics to supplement the conventional diagnostic imaging goals of depicting tumor location, size, and morphology. Hybrid imaging techniques combine anatomic [ultrasound, computed tomography (CT), and/or magnetic resonance imaging (MRI)] and molecular (single photon emission CT and positron emission tomography) imaging modalities. One example is real-time virtual sonography, which combines ultrasound (grayscale, colour Doppler, or dynamic contrast harmonic imaging) with contrast-enhanced CT/MRI. The benefits of fusion imaging include an increased diagnostic confidence, direct comparison of the lesions using different imaging modalities, more precise monitoring of interventional procedures, and reduced radiation exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
48. Hybrid ultrasound imaging techniques (fusion imaging).
- Author
-
Sandulescu, Daniela Larisa, Dumitrescu, Daniela, Rogoveanu, Ion, and Saftoiu, Adrian
- Subjects
- *
CONTRAST-enhanced magnetic resonance imaging , *NEOVASCULARIZATION , *RADIATION exposure , *DOPPLER ultrasonography , *PRECANCEROUS conditions , *CANCER diagnosis - Abstract
Visualization of tumor angiogenesis can facilitate noninvasive evaluation of tumor vascular characteristics to supplement the conventional diagnostic imaging goals of depicting tumor location, size, and morphology. Hybrid imaging techniques combine anatomic [ultrasound, computed tomography (CT), and/or magnetic resonance imaging (MRI)] and molecular (single photon emission CT and positron emission tomography) imaging modalities. One example is real-time virtual sonography, which combines ultrasound (grayscale, colour Doppler, or dynamic contrast harmonic imaging) with contrast-enhanced CT/MRI. The benefits of fusion imaging include an increased diagnostic confidence, direct comparison of the lesions using different imaging modalities, more precise monitoring of interventional procedures, and reduced radiation exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
49. Hybrid ultrasound imaging techniques (fusion imaging).
- Author
-
Sandulescu, Daniela Larisa, Dumitrescu, Daniela, Rogoveanu, Ion, and Saftoiu, Adrian
- Subjects
- *
ULTRASONIC imaging , *CONTRAST-enhanced magnetic resonance imaging , *NEOVASCULARIZATION inhibitors , *DRUG monitoring , *RADIATION exposure , *MOLECULAR diagnosis - Abstract
Visualization of tumor angiogenesis can facilitate noninvasive evaluation of tumor vascular characteristics to supplement the conventional diagnostic imaging goals of depicting tumor location, size, and morphology. Hybrid imaging techniques combine anatomic [ultrasound, computed tomography (CT), and/or magnetic resonance imaging (MRI)] and molecular (single photon emission CT and positron emission tomography) imaging modalities. One example is real-time virtual sonography, which combines ultrasound (grayscale, colour Doppler, or dynamic contrast harmonic imaging) with contrast-enhanced CT/MRI. The benefits of fusion imaging include an increased diagnostic confidence, direct comparison of the lesions using different imaging modalities, more precise monitoring of interventional procedures, and reduced radiation exposure. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
50. MMR Gene Expression Pattern in Sporadic Colorectal Cancer.
- Author
-
Ioana, Mihai, Angelescu, Cristina, Burada, Florin, Mixich, Francisc, Riza, Anca, Dumitrescu, Theodor, Alexandru, Dragos, Ciurea, Tudorel, Cruce, Mihai, and Saftoiu, Adrian
- Subjects
- *
GENE expression , *COLON cancer , *GENETIC regulation , *POLYPS , *MESSENGER RNA , *CANCER patients , *BIOMARKERS , *PRESERVATION of organs, tissues, etc. , *TISSUE banks - Abstract
Background and aims: Colorectal carcinoma is the second leading cause of death by cancer in Europe as its incidence increases with life span. Continuing research to detect new highly sensitive and specific noninvasive biomarkers is essential. The aim of this study was to compare 9 mismatching repair (MMR) genes activation levels in normal, polyp and malignant tissues in order to detect a MMR gene expression pattern in sporadic colorectal malignant pathology. Methods: MMR mRNA levels were evaluated in tumor - normal tissue paired samples and polyps collected from 29 patients undergoing standard surgical procedures with curative intention. Real-Time quantitative Reverse Transcription PCR (qRT PCR) with TaqMan probes specific to ANKRD17, EXO1, MLH1, MLH3, MSH2, MSH3, MSH4, MSH5, MSH6 gene transcripts were used. Results: The general tendency observed was a lower mRNA level of MMR genes in tumor samples compared with the normal tissue, with the exception of EXO1 gene. The number of patients that showed a higher expression of MMR genes in normal tissue was significantly greater than the number of patients that showed a higher expression inside the tumor (p=0.0024). ANKRD17 mRNA levels were higher in normal tissue than in tumor for 16 cases, by contrast with only 6 cases of higher mRNA levels in tumor. Conclusions: ANKRD17 mRNA appears to be the most sensitive target and may have a potential value as an additional marker for the existing multitarget assay panel for colorectal cancer detection. [ABSTRACT FROM AUTHOR]
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.